ArticleJournal of immunology (Baltimore, Md. : 1950)2026
Suppression of pre-B cell colony formation by catecholamine oxidation.
Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The sympathetic nervous system regulates many aspects of lymphocyte function by stimulating adrenergic receptors with catecholamines. To determine the effects of β-adrenergic receptor (β-AR) signaling on B cell development, we utilized the pre-B cell colony forming unit (CFU-Pre-B) assay and found that isoproterenol (ISO), a β-AR selective catecholamine, potently suppresses pre-B cell colony formation. Further investigation using selective agonists and knockout mice showed that the colony suppression was independent of adrenergic receptor signaling. This colony suppression was replicated by treatment with epinephrine and other catecholamines and was reversed with the addition of an antioxidant. Catecholamine oxidation was reasoned to cause the suppression, as this reaction generates reactive oxygen species (ROS) and toxic products. Further experiments with CFU-Pre-B assays revealed a sensitivity to ambient oxygen and oxidative stress generated by menadione treatment. Analysis of cells within the ISO treated colonies revealed alterations in the distribution of pre- and pro-B cells at different stages of development and indicated delays in maturation. ISO treatment was not found to be immediately toxic within the timeframe of expected ISO oxidation, but a loss of cells with colony forming potential was observable once colonies started to grow. B cell progenitors showed a greater sensitivity to ISO or menadione treatment than myeloid and erythroid progenitors. Our study demonstrates an unexpected hypersensitivity of B cell progenitors to oxidative stress generated by catecholamine oxidation. This study also highlights the importance of additional controls when assessing neuroimmune interactions assumed to be mediated by signaling through adrenergic or dopaminergic receptors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.